share_log

Bristol Myers Squibb Secures Positive CHMP Opinion For CAR T Cell Therapy Breyanzi For Relapsed Or Refractory Large B-cell Lymphoma After One Prior Therapy

Bristol Myers Squibb Secures Positive CHMP Opinion For CAR T Cell Therapy Breyanzi For Relapsed Or Refractory Large B-cell Lymphoma After One Prior Therapy

Bristol Myers Squibb 获得了 CHMP 对 CAR T 细胞疗法 Breyanzi 的积极评价 Breyanzi 治疗先前一次治疗后的复发或难治性大 B 细胞淋巴瘤
Benzinga ·  2023/03/31 20:10

Bristol Myers Squibb Secures Positive CHMP Opinion For CAR T Cell Therapy Breyanzi For Relapsed Or Refractory Large B-cell Lymphoma After One Prior Therapy

Bristol Myers Squibb 获得了 CHMP 对 CAR T 细胞疗法 Breyanzi 的积极评价 Breyanzi 治疗先前一次治疗后的复发或难治性大 B 细胞淋巴瘤

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发